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The Hippo tumor suppressor pathway is essential for development and tissue growth control,
encompassing a core cassette consisting of the Hippo (MST1/2), Warts (LATS1/2), and
Tricornered (NDR1/2) kinases together with MOB1 as an important signaling adaptor.
However, it remains unclear which regulatory interactions between MOB1 and the different
Hippo core kinases coordinate development, tissue growth, and tumor suppression. Here, we
report the crystal structure of the MOB1/NDR2 complex and deﬁne key MOB1 residues
mediating MOB1’s differential binding to Hippo core kinases, thereby establishing MOB1
variants with selective loss-of-interaction. By studying these variants in human cancer cells
and Drosophila, we uncovered that MOB1/Warts binding is essential for tumor suppression,
tissue growth control, and development, while stable MOB1/Hippo binding is dispensable and
MOB1/Trc binding alone is insufﬁcient. Collectively, we decrypt molecularly, cell biologically,
and genetically the importance of the diverse interactions of Hippo core kinases with the
pivotal MOB1 signal transducer.
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The Hippo pathway is vital for organ growth control andtissue homeostasis1–3, and its dysregulation has beenlinked to various human cancers4. Therefore, it is
imperative to understand how major core components of the
Hippo pathway are regulated in different cellular contexts in
health and disease. The Hippo tumor suppressor pathway signals
through three main levels: (i) a central core kinase cassette, (ii)
downstream regulators of transcriptional programs, and (iii)
diverse upstream regulators1–4. The Drosophila core cassette
comprises the Warts (Wts) and Hippo (Hpo) kinases supported
by the adaptor protein Mats5, 6. The Hpo-Wts-Mats cassette acts
together to inhibit Yorkie (Yki), which when uncontrolled pro-
motes tissue overgrowth7. The Hippo core cassette is conserved
from ﬂies to humans, with human MST2, LATS1, and MOB1A
compensating for Hpo, Wts, and Mats loss-of-function, respec-
tively8–10. Thus, Drosophila is well suited for in vivo studies of
essential molecular mechanisms in Hippo core signaling5, 11.
The mammalian Hippo core cassette contains MST1/2,
LATS1/2, and MOB1 which together regulate the transcriptional
co-activators YAP/TAZ12, 13. MST1/2, LATS1/2, MOB1, and
YAP/TAZ are the human equivalents of ﬂy Hpo, Wts, Mats, and
Yki7, 14–16. Upon activation MST1/2 phosphorylates LATS1/2
and MOB1 to support formation of an active MOB1/LATS
complex, which phosphorylates YAP/TAZ, promoting its cyto-
plasmic retention and/or degradation3. The NDR1/2 kinases, the
closest relatives of LATS1/215, are also controlled by MST1/2 and
MOB117, and regulate YAP18. Thus, the Hippo core pathway can
act through distinct kinases, with MOB1 acting as a fundamental
signal adaptor that can interact with the Hippo core kinases
MST1/2, LATS1/2, and NDR1/216, 19–22.
MOB proteins are highly conserved amongst eukaryotes,
constituting signal transducers in essential processes via their
regulatory interactions with NDR/LATS16. In Drosophila, Mats
(aka dMOB116) can function together with Wts and Hpo in
Hippo signaling10, 23. However, Mats also interacts genetically
with Trc24, the ﬂy counterpart of human NDR1/215. Mammals
express at least six MOBs, with MOB1A and MOB1B sharing
95% sequence identity16. MOB1A/B (aka MOB1) can function
redundantly as regulators of LATS1/2 signaling21, 25–27, but are
also required for NDR1/2 activation16, as an alternative branch17,
18 of the Hippo core cassette. Biochemical evidence suggests that
MOB1 can associate with the highly conserved
N-terminal regulatory domain (NTR) of NDR/LATS kinases to
promote their activities15, 16, 25. MST1/2 phosphorylation of
MOB1 can inﬂuence MOB1 binding to the NTR19, 20, 22, 28, 29,
although it is yet to be determined whether this phosphorylation
is required for NDR/LATS kinase activity in vivo. Nevertheless,
MOB1 (Mats) is very likely acting as a central molecular switch in
Hippo signaling3, 30. However, we still lack structural and mole-
cular insights on how the regulatory bindings of MOB1 to MST1/
2, LATS1/2, or NDR1/2 are mediated and how MOB1 differ-
entiates between these interactions. Two crystal structures of
MOB1 bound to LATS1 were reported19, 20, but the crystal
structure of the MOB1/NDR complex has yet to be documented.
The importance of stable MOB1 binding to MST1/2 (Hpo) is
currently also debatable based on recently published
biochemical data and the analysis of a chimeric conformation
sensor19, 20, 28–31. In general, the biological signiﬁcance of MOB1
interactions with Hippo core kinases is not deﬁned for tumor
suppression, development, and tissue growth control (Supple-
mentary Fig. 1a).
Here, we report our structural, biochemical, cell biological, and
organismal studies of the importance of MOB1 interactions with
Hippo core kinases. The overall crystal structure of MOB1 bound
to NDR2 is very similar to the previously reported structures of
MOB1/LATS119, 20. However, by comparing these crystal
structures we could identify Asp63 as a key MOB1 residue that
speciﬁcally mediates binding to LATS1. Thus, we characterized
the interactions of Hippo core kinases with full-length MOB1
variants carrying speciﬁc point mutations, resulting in the dis-
covery of MOB1 variants that are selectively impaired in their
binding to MST1/2 (Hpo) or LATS1/2 (Wts) in human and ﬂy
cells. Using these MOB1 variants with selective loss-of-interac-
tion, we found that a stable interaction of MOB1 with LATS1/2,
but not with MST1/2, is essential for tumor suppressive proper-
ties of MOB1 in human cancer cells. By employing ﬂy genetics,
we discovered that the MOB1/Wts interaction is essential for
development and tissue growth control, while stable MOB1
binding to Hpo is dispensable. Taken together, our study decrypts
the nature and functional importance of the diverse interactions
of Hippo core kinases with the central MOB1 signaling adaptor.
Results
Crystal structure of MOB1 bound to the NTR of human
NDR2. To delineate the interaction of MOB1 with NDR2 on the
atomic level, we determined the crystal structure of the
MOB1/NDR2 complex at 2.1 Å using puriﬁed MOB1 (residues
33–216) and the NTR of NDR2 (residues 25–88) (Fig. 1a–c and
Table 1). The structure of MOB1 adopts a globular shape con-
sisting of nine α-helices (α1–α9) and two β-strands (Fig. 1a), as
reported for unbound human MOB119, 32, frog MOB133, and
yeast Mob1p34. The overall structure of the MOB1/NDR2 com-
plex is similar to the reported MOB1/LATS1 complex19, 20, since
NDR2 binds to MOB1 in a V-shaped structure composed of two
antiparallel α-helices (Fig. 1a–c). In agreement with biochemical
studies15, 17, 25, highly conserved positively charged residues of
NDR2 bond with negatively charged electrostatic surfaces of
MOB1 (Fig. 1b, c).
The central intermolecular interactions between MOB1 and
NDR2 are hydrogen bonds and van der Waals interactions
(Fig. 1d), with the two antiparallel α-helices of NDR2 represent-
ing two interaction interfaces (Fig. 1e, f). In the α1 helix Lys25,
Leu28, Tyr32, Leu35, and Ile36 of NDR2 interact with Leu36,
Gly39, Leu41, Ala44, Gln67, Met70, Leu71, Leu173, Gln174, and
His185 of MOB1 (Figs. 1d, e and 2a). In the α2 helix Arg42,
Leu78, Arg79, and Arg82 of NDR2 interact with Glu51, Glu55,
Trp56, Val59, Phe132, Pro133, Lys135, and Val138 of MOB1
(Figs. 1d, f and 2a). The V-shape of the bihelical NTR domain of
NDR2 is stabilized by intramolecular interactions of Arg45 and
Glu50 in the α1 helix with Arg67 and Glu74 in the α2 helix
(Fig. 1f).
Our structural data are supported by previous biochemical
studies of NDR1 (NDR2) variants carrying single point mutations
at K24A (K25A), Y31A (Y32A), R41A (R42A), R44A (R45A),
T74A (T75A), or R78A (R79A) in the context of MOB1 binding
and NDR1/2 activation15, 17, 25. Biochemical studies of LATS1/2
mutants carrying substitutions of the residues corresponding to
Arg42, Arg45, Glu74, Thr75, Arg79, or Arg82 of NDR2 also
demonstrated the importance of these conserved residues for
MOB1 binding and LATS1/2 activation19–21, 35, 36.
MOB1 binds differently to the NTRs of NDR2 and LATS1
kinases. To deﬁne possible differences between MOB1/NDR2 and
MOB1/LATS1 complexes, we compared available MOB1/
LATS1 structures19, 20 with our MOB1/NDR2 structure (Fig. 1).
This revealed fully conserved core interactions, but also dissim-
ilarities (Fig. 2b and Supplementary Fig. 2). Most signiﬁcantly, we
discovered that His646 of LATS1 bonds with Asp63 of MOB1
(Fig. 2b) supported by a cluster of surrounding residues involving
Phe642, Met643, Gln645, Val647, and Val65019, while Phe31 of
NDR2 does not interact with Asp63 of MOB1 (Figs. 1d, e and 2a,
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b). Consequently, our structural comparison suggests that Asp63
of MOB1 speciﬁcally bonds with LATS kinases through His646
(Fig. 2b), which is conserved in human LATS1/2 and ﬂy Wts, but
replaced by a bulky Phe/Tyr residue in human NDR1/2 and ﬂy
Trc (Fig. 2a). Thus, our evidence indicates that MOB1 binds
differently to NDR vs. LATS kinases.
To investigate whether the interaction thermodynamics differ,
we performed isothermal titration calorimetry (ITC) assays to
determine the dissociation constant (Kd) of full-length MOB1
with the NTRs of NDR1, NDR2, LATS1, or LATS2 (Fig. 2c–f and
Supplementary Fig. 3). Signiﬁcantly, unphosphorylated full-
length MOB1 bound to NDR1 and NDR2 (Fig. 2c, left panel
and Supplementary Fig. 3a), while an interaction with LATS1 or
LATS2 was undetectable (Fig. 2d, left panel, and Supplementary
Fig. 3b). MOB1(Q67A) and MOB1(H185A) mutants did not
interact with NDR2 (Supplementary Fig. 4), illustrating that the
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observed MOB1/NDR2 interaction is speciﬁc. Considering that
MST1/2 phosphorylation of MOB1 can inﬂuence in vitro MOB1
binding to the NTR of LATS119, 20, 22, 28, 29, we measured the Kd
of MST1/2-phosphorylated full-length MOB1 (phospho-MOB1)
with NDR1, NDR2, LATS1, or LATS2 (Fig. 2c, d, right panels,
and Supplementary Fig. 3a, b). This revealed that MOB1
phosphorylation is essential for MOB1 binding to LATS1 or
LATS2 in our experimental settings using protein fragments
representing the NTR domains (Fig. 2d and Supplementary
Fig. 3b). We further uncovered that NDR1 and NDR2 bound with
enhanced afﬁnity to phospho-MOB1 than to non-phosphorylated
MOB1 (Fig. 2c and Supplementary Fig. 3a). Phospho-MOB1 also
bound with an at least 15-fold (or higher) increased afﬁnity to
NDR1 or NDR2 compared to LATS1 or LATS2 (Fig. 2c, d, right
panels and Supplementary Fig. 3a, b).
Since we discovered Asp63 of MOB1 as a potential key
determinant in the differential binding of MOB1 to NDR2 vs.
LATS1 (Fig. 2b), we tested the contribution of residues
surrounding His646 of LATS1 and Phe31 of NDR2 to MOB1
binding. Speciﬁcally, considering that Tyr32 of NDR2 (and Tyr31
of NDR1, respectively) is essential for MOB1 binding and kinase
activation15, 17, 25, but not conserved in LATS1/215, 17, 25, we
hypothesized that by switching Val647 of LATS1 (or Val610 of
LATS2) to a tyrosine we may change the binding afﬁnities of
LATS1 and LATS2 into the ones observed for NDR1 and NDR2.
Thus, we studied NDR1(Y31V), NDR2(Y32V), LATS1(V647Y),
and LATS2(V610Y) mutants. As expected based on the central
role of Tyr32 in MOB1/NDR2 complex formation (Figs. 1e and
2a), NDR2(Y32V) and NDR1(Y31V) did not associate with non-
phosphorylated MOB1 (Fig. 2e, left panel, and Supplementary
Fig. 3c). However, NDR2(Y32V) and NDR1(Y31V) bound to
phospho-MOB1 (Fig. 2e, right panel, and Supplementary Fig. 3c),
although with a 20-fold decreased binding afﬁnity compared to
wild-type NDR2 or NDR1, respectively (compare Fig. 2c, e and
Supplementary Fig. 3a, c). Signiﬁcantly, LATS1(V647Y) and
LATS2(V610Y) interacted with non-phosphorylated MOB1 with
a similar Kd as observed between wild-type LATS1 or LATS2 and
phospho-MOB1 (compare Fig. 2d, f and Supplementary Fig. 3b,
d). LATS1(V647Y) and LATS2(V610Y) even displayed a 5-fold
increased binding afﬁnity for phospho-MOB1 compared to wild-
type LATS1 or LATS2, respectively (compare Fig. 2d, f, and
Supplementary Fig. 3b, d).
Taken together, we demonstrate in Figs. 1 and 2 that MOB1
relies on different residues to bind to NDR2 and LATS1. MST1/2
phosphorylation of MOB1 can play a signiﬁcant role in
modulating in vitro the diverse binding afﬁnities of MOB1 to
the NTRs of NDR/LATS kinases. MOB1/NDR2 complex
formation is dramatically increased by prior MST1/2 phosphor-
ylation of MOB1, while the MOB1/LATS1 interaction appears to
be fully dependent on MST1/2 phosphorylation of MOB1. In this
regard, a single substitution of Val647 to Tyr of LATS1 (or
Val610 of LATS2) is sufﬁcient to support MOB1/LATS complex
formation independent of MOB1 phosphorylation. More speci-
ﬁcally, LATS1(V647Y) and LATS2(V610Y) bound to non-
phospho and phospho-MOB1 with much increased afﬁnities as
observed for LATS1 and LATS2 wild-type, hence indicating that a
single substitution in LATS1 or LATS2 can switch the binding
mode of LATS kinases. Noteworthy, these conclusions are solely
based on our ITC assays (Fig. 2 and Supplementary Fig. 3), hence
the in vivo relevance has yet to be determined. In this regard, it
has been documented that unphosphorylated MOB1 can bind to
a LATS1 fragment in vitro19, 20. Therefore, more research is
needed to decipher the reason(s) for this discrepancy. Possibly
our ITC assay requires higher concentrations to detect lower
afﬁnity interactions, or ITC assays with higher afﬁnity kinase
fragments are necessary. Certainly, identical kinase fragments will
need to be tested to allow a proper comparison of our ﬁndings
(Fig. 2 and Supplementary Fig. 3) with previous studies19, 20, but
most importantly, the in vivo implications of MST1/2 (Hpo)
phosphorylation of MOB1 need to be delineated in future studies.
Fig. 1 The crystal structure of the MOB1/NDR2 complex reveals phosphorylation-independent interactions of MOB1 with NDR2 through conserved
interfaces. a Overall crystal structure of the complex between human MOB1A (residues 33–216) and human NDR2 (residues 25–88). MOB1 and NDR2 are
colored in magenta and green, respectively. The Zinc associated with MOB1 is indicated in gray. Secondary structure elements are highlighted. b The
negatively charged surface of MOB1 recognizes positively charged residues on NDR2. The electrostatic surface potential of MOB1 is shown (red: negatively
charged residues; blue: positively charged residues). NDR2 is shown as a ribbon representation colored in green. c The MOB1/NDR2 binding surfaces are
highly conserved. The residues of MOB1 are gradually colored according to conservation scores (dark red: most conserved residues; dark cyan: least
conserved residues). NDR2 is shown as a ribbon representation colored in green. d Structure based sequence alignment of MOB1 from indicated species.
MOB1 residues mediating interactions with NDR2 are marked with brown (main-chain hydrogen bonds), green (side-chain hydrogen bonds), and magenta
circles (van der Waals interactions). α helices are painted with cyan background. Thr12 and Thr35 phosphorylation sites are indicated by red arrows. e, f The
interaction interfaces of MOB1 with the α1 (residues 25–56) and α2 (residues 61–84) helices of NDR2. MOB1 and NDR2 and their key interacting residues
are shown in pink and green, respectively. Dashed lines represent hydrogen bonds. Side-chain nitrogen, oxygen, and sulfur atoms of MOB1 and NDR2
residues are colored in blue, red and gold, respectively. The hydrogen bond network connecting the α1 and α2 helices of NDR2 is also illustrated in f. For a
stereo image of a portion of the electron density map see Supplementary Fig. 18
Table 1 Data collection and reﬁnement statistics
Data collection
Space group P212121
Unit-cell parameters a= 57.5 Å, b= 94.4 Å,
c= 102.2 Å; α= β= γ= 90°
Number of molecules/asymmetric unit 2
Resolution range (Å) 50-2.10 (2.18-2.10)
Completeness (%) 99.6 (100.0)
Redundancy 6.9 (6.4)
Total observations 226,859
Unique reﬂections 32,723
Rmerge (%) 10.0 (61.3)
I/σI 16.3 (3.1)
Reﬁnement
Rwork (%) 15.3
Rfree (%) 24.4
Overall B factor 42.3
RMSD bond lengths (Å) 0.013
RMSD bond angles (°) 1.507
Ramanchandran plot (favored, allowed,
disallowed, %)
99.0, 0.6, 0.4
Final model (number of protein/solvent
atoms)
4,149/267
RMSD root-mean-square deviations from ideal geometry. Rmerge= ΣhΣi|Ih,i−Ih|/ΣhΣiIh,i for the
intensity (I) of observation i of reﬂection h. R factor = Σ||Fobs|−|Fcalc||/Σ|Fobs|, where Fobs and Fcalc
are the observed and calculated structure factors, respectively. Rfree = R factor calculated using
5% of the reﬂection data chosen randomly and omitted from the start of reﬁnement. Data for
the highest resolution shell are shown in parentheses
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Deﬁning MOB1 variants with selective loss-of-interactions. To
empower the translation of our structural and biochemical ﬁnd-
ings into studies of human cells and ﬂies, we studied the inter-
actions of full-length human MOB1 variants with human/ﬂy
Hippo core kinases (Fig. 3 and Supplementary Figs. 5–7).
In human HEK293 cells myc-tagged MOB1 mutants were
co-expressed with HA-tagged wild-type kinases, followed by
co-immunoprecipitation experiments in low-stringency condi-
tions (Supplementary Figs. 5–7). Moreover, myc-tagged MOB1
binding to ﬂy HA-tagged Wts, Trc, and Hpo was examined in
Drosophila S2R + cells (Supplementary Figs. 5e, 6e, f, and 7e).
These experiments revealed that MOB1(D63V) does not form
stable complexes with LATS1/2 or Wts, while stably associating
with NDR1/2, Trc, MST1/2, and Hpo (Supplementary Figs. 5–7).
a b
C
e f
d
30
70 80
88
703
87
666
717
91
175
350
206
91
Interacting with MOB1
Time (min) Time (min) Time (min) Time (min)
0 0
0.00 0.00
0.10
0.05
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
3.
5
4.
0
4.
5 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5
5.
0
0.00
–0.05
–0.10
–0.50
–1.00
–0.10
–0.20
–0.20
–0.40
–0.60
–0.80
–0.30
0.0
μc
al
/s
ec
μc
al
/s
ec
K
ca
l m
ol
–1
of
 im
je
ct
an
t
K
ca
l m
ol
–1
of
 im
je
ct
an
t
0.0
0
0 10 20 30 0 10 30 10 100 020 203020
01 12 23 3
MOB1 +
NDR2 (25-88)
MOB1 +
NDR2 (25-88, Y32V)
No detectable interaction
Phospho-MOB1
+ NDR2 (25-88)
MOB1 +
LATS1 (640-703)
Molar ratio Molar ratio Molar ratio Molar ratio
No detectable
interaction
Kd= 12.3 μM Kd= 0.578 μM
Phospho-MOB1
+ LATS1 (640-703)
K
d
= 19.6 μM
Phospho-MOB1+
LATS1 (640-703, V647Y)
4 4 6 75
–1.0
–2.0
–3.0
0.2 0.00 0.00 0.00
–0.05
–0.10
–0.15
–0.20
–0.25
0.0
–2.0
–0.02
–0.04
–0.06
–0.08
–0.10
0.00
–0.20
–0.40
–0.60
–0.80
–0.20
–0.40
–0.60
–0.80
0.0
–4.0
–8.0
–12.0
–16.0
0.00
–0.02
–0.04
–0.06
0.00
–0.20
–0.40
–0.60
–0.80
4 4 0 075 6 6 8 10
4 42 2313 32 21 10 0
–4.0
–8.0
–12.0
–16.0
10 1020 2030 30 20 2010 100 0
0.00
–0.05
–0.10
–0.15
–0.20
0.0
–0.2
–0.4
–0.6
–0.8
–1.0
Mediating NDR2 intramolecular interactions
167
40
α1
α2
50 60
MOB1
MOB1
D63
D63
Human NDR2 (25-88)
F31
NDR2
H646
LATS1
Human NDR2 (25-88)
Human NDR1 (24-87)
Human NDR1 (24-87)
Human LATS1 (640-703)
Human LATS1 (640-703)
Human LATS2 (603-666)
Human LATS2 (603-666)
Drosophila Wts (654-717)
Drosophila Wts (654-717)
Drosophila Tricornered (28-91)
Drosophila Tricornered (28-91)
S. cerevisiae Dbf2 (108-175)
S. cerevisiae Dbf2 (108-175)
S. cerevisiae Dbf20 (100-167)
S. cerevisiae Dbf20 (100-167)
S. cerevisiae Cbk1 (287-350)
S. cerevisiae Cbk1 (287-350)
S. pombe Sid2 (145-206)
S. pombe Sid2 (145-206)
S. pombe Orb6 (28-91)
S. pombe Orb6 (28-91)
24
640
25
603
654
28
108
100
287
145
28
Time (min) Time (min) Time (min) Time (min)
Molar ratio Molar ratio Molar ratio Molar ratio
K
ca
l m
ol
–1
of
 im
je
ct
an
t
μc
al
/s
ec
Phospho-
MOB1 +
NDR2 (25-88, Y32V)
MOB1 + LATS1
(640-703, V647Y)
Kd= 9.90 μM
Kd= 16.9 μM Kd= 4.42 μMK
ca
l m
ol
–1
of
 im
je
ct
an
t
μc
al
/s
ec
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00795-y ARTICLE
NATURE COMMUNICATIONS |8:  695 |DOI: 10.1038/s41467-017-00795-y |www.nature.com/naturecommunications 5
Thus, together with our structural data (Figs. 1 and 2) these
ﬁndings indicate that Asp63 of MOB1 plays a speciﬁc role in
MOB1 binding to ﬂy and human LATS kinases.
To study the entire spectrum of MOB1 interactions with Hippo
core kinases (Supplementary Fig. 1a), we next determined key
residues mediating MOB1 binding to MST1/2 and Hpo. As
observed for the MOB1 interactions with NDR/LATS kinases
(Figs. 1 and 2 and refs. 19, 20), we speculated that charged residues
of MOB1 are also centrally important for stable complex
formation with human MST1/2 and ﬂy Hpo. Consequently, we
performed co-immunoprecipitation assays with MST1/2 and a
panel of MOB1 variants. Signiﬁcantly, a MOB1(K104E/K105E)
version failed to stably bind to MST1/2 and Hpo (Fig. 3a, b).
MOB1(K104E/K105E) displayed selective loss-of-interaction with
MST1/2 and Hpo since it was still proﬁcient in binding to LATS1/
2, Wts, NDR1/2 or Trc (Fig. 3a, b and Supplementary Figs. 5–7).
Moreover, unlike wild-type MOB1, MOB1(K104E/K105E) did
not associate with human MST2 in three additional co-
immunoprecipitation conditions (Supplementary Fig. 8). Collec-
tively, these data suggest that Lys104 and Lys105 of MOB1 play
speciﬁc roles in MOB1 binding to Hpo and MST1/2.
In the hope to generate an alternative MOB1 variant displaying
selective loss-of-interaction with MST1/2 and Hpo, we considered
modiﬁcations of the MOB1 residues Lys153 and Arg154 as
promising candidates due to their central roles in the phospho-
threonine binding interface supporting MOB1/MST1 and MOB1/
MST2 interactions20, 28. However, MOB1(K153A/R154A) and
MOB1(K153E/R154E) displayed defective interactions with full-
length wild-type MST2 and LATS2, while NDR1 binding was
intact (Supplementary Fig. 9). MOB1(K153A/R154A) and MOB1
(K153E/R154E) were also defective in Wts and Hpo binding,
while they bound to Trc in insect cells (Supplementary Fig. 9).
Thus, as suggested previously37, as central P0 phosphate
coordinating residues28, 37, Lys153 and Arg154 are likely to
represent the core of a more general phospho-serine/threonine
binding domain of MOB1. This conclusion is reinforced by the
ﬁnding that the region surrounding Lys153 and Arg154 of MOB1
also supports Praja2 binding38. As a result, we concluded that
Lys153 and Arg154 modiﬁcations of MOB1 are not suitable to
develop MOB1 variants with selective loss-of-interaction with
MST1/2 and Hippo.
Since MOB1(E51K) is deﬁcient in NDR1/2 binding39, we also
proﬁled MOB1(E51K) (Supplementary Figs. 5–7).
However, as summarized in Fig. 3c, MOB1(E51K) associated
inconsistently with Hippo core kinases and was therefore
excluded from further cellular studies. Alternatively, we engi-
neered a MOB1(D63V/K104E/K105E) mutant to establish a
MOB1 version that only associates with NDR1/2, but not
with LATS1/2 and MST1/2 (Fig. 3c and Supplementary
Figs. 5–7).
To complete the biochemical characterization, we performed
additional experiments. First, we investigated the importance of
Asp63 and Lys104/Lys105 of MOB1 for in vitro binding to Hippo
core kinases using gel ﬁltration chromatography, revealing that
recombinant full-length MOB1(D63V) and MOB1(K104E/
K104E) displayed the same binding patterns as observed for
full-length proteins expressed in human and ﬂy cells (Fig. 3c and
Supplementary Fig. 10). Second, we performed ITC assays to
determine the dissociation constant of full-length MOB1(K104E/
K105E) with the NTRs of NDR1, NDR2, LATS1, and LATS2
(Supplementary Fig. 11). Unphosphorylated MOB1(K104E/
K105E) bound to all four NTRs comparable to unphosphorylated
wild-type MOB1 (compare Fig. 2 and Supplementary Figs. 3 and
11). Likewise, phospho-MOB1(K104E/K105E) displayed similar
afﬁnities to all four NTRs as observed for wild-type MOB1
(compare Fig. 2 and Supplementary Figs. 3 and 11). Binding of
MOB1(K104E/K105E) to NDR1(Y31V), NDR2(Y32V), LATS1
(V647Y), and LATS2(V610Y) NTR mutants was also comparable
to wild-type MOB1 (compare Fig. 2 and Supplementary Figs. 3
and 11). Third, we measured MST1/2 (Hpo) phosphorylation of
our MOB1 variants (Supplementary Figs. 12 and 13), since MOB1
phosphorylation can inﬂuence the binding afﬁnities of MOB1 to
NDR/LATS (Fig. 2 and refs. 19, 22, 28, 29). MST1/2 (Hpo)
phosphorylation of MOB1 on Thr12 and Thr35 was comparable
for all MOB1 versions tested (Fig. 3c and Supplementary Figs. 12
and 13). Thus, the selective loss-of-interaction of MOB1(D63V) is
not a consequence of altered Thr12/Thr35 phosphorylation, but
rather caused by the substitution of a key residue that is essential
for MOB1/LATS complex formation. Our data (Fig. 3 and
Supplementary Figs. 7–13) further argue that a stable interaction
of MST1/2 (Hpo) with MOB1 is not required for MOB1
phosphorylation by MST1/2 (Hpo).
Taken together, we discovered that distinct MOB1 residues
mediate the interactions with the different mammalian and ﬂy
Hippo core kinases. Speciﬁcally, Asp63 and Lys104/Lys105 of
MOB1 represent key residues mediating the differential binding
properties of MOB1 with LATS1/2 (Wts) and MST1/2 (Hpo),
respectively (Fig. 3d).
Testing of MOB1 variants in anchorage-independent growth.
To deﬁne which MOB1 interactions with Hippo core kinases are
necessary for tumor suppression, we engineered pools of MCF-7
human breast cancer cells stably expressing either empty vector
(EV), HA-MOB1 wild-type (wt), HA-MOB1(D63V), HA-MOB1
(K104E/K105E), or HA-MOB1(D63V/K104E/K105E) (Fig. 4a).
Then, we determined proliferation and colony formation in two-
dimensional (2D) culture conditions. Speciﬁcally, we measured
proliferation using IncuCyte live cell analysis technology (Fig. 4b)
and performed colony formation assays (Fig. 4c, d) to determine
Fig. 2 MOB1 binds differently to the NTR domains of NDR2 and LATS1 through key residues. a Structure based sequence alignment of the conserved N-
terminal regulatory domain of NDR/LATS kinases that is required for MOB1 binding. NDR2 residues mediating interactions with MOB1 are marked with red
circles. Residues mediating intramolecular interactions of NDR2 are denoted by blue triangles. Residues conserved from yeast to humans are highlighted in
green, while residues conserved in at least seven of the conserved NDR/LATS family members are marked in cyan. α helices are indicated with gray rods. b
Asp63 of MOB1 is involved in LATS1 binding, but does not contribute to the interaction of MOB1 with NDR2. MOB1 is shown in yellow, while NDR2 and
LATS1 are indicated in green and cyan, respectively. Top panel, Phe31 of NDR2 does not interact with Asp63 of MOB1. Bottom panel, His646 of LATS1 forms
a hydrogen bond with Asp63 of MOB1. c–f Isothermal titration calorimetry (ITC) assays measuring the dissociation constant (Kd) of indicated non-
phosphorylated full-length MOB1 or MST2-phosphorylated MOB1 (phospho-MOB1) with wild-type and mutant NDR2 (25–88) or LATS1 (640–703)
variants. MOB1/NDR2 complex formation was dramatically increased by prior phosphorylation of MOB1 c. ITC measurements could not detect any
interaction between LATS1 wild-type and non-phosphorylated MOB1, while phospho-MOB1 bound to LATS1 d. The NDR2(Y32V) mutant did not associate
with non-phosphorylated MOB1, but bound to phospho-MOB1, although with a 20-fold decreased binding afﬁnity compared to wild-type NDR2 (e). The
mutation of Val647 to Tyr of LATS1 enabled LATS1 to bind to non-phosphorylated MOB1, and LATS1(V647Y) displayed a 5-fold increased binding afﬁnity
for phospho-MOB1 compared to wild-type LATS1 (f)
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cell survival based on the ability of single cells to grow into
colonies40. Expression of all MOB1 variants resulted in decreased
proliferation in 2D compared to controls (Fig. 4b). Likewise,
except for MOB1(D63V/K104E/K105E), our MOB1 variants
reduced colony formation (Fig. 4c, d). Transient expression of our
MOB1 variants in HCT116 colon cancer cells also diminished
proliferation and colony formation in 2D (Supplementary
Fig. 14). These data show that MOB1(D63V) and MOB1(K104E/
K105E) suppress proliferation and colony formation similarly to
MOB1(wt), suggesting that the interactions of MOB1 with
LATS1/2 and MST1/2 are dispensable. Considering that MOB1
(D63V) and MOB1(K104E/K105E) still bind to NDR1/2 (Fig. 3c
and Supplementary Fig. 6) and that MOB1(K104E/K105E) is
phosphorylated on Thr12 and Thr35 in MCF-7 cells comparable
to wild-type MOB1 (Supplementary Fig. 15), we are therefore
tempted to conclude that MOB1 binding to NDR1/2 can be
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Fig. 3 Deﬁnition of MOB1 variants with selective loss-of-interaction with Hippo core kinases. a Lysates of HEK293 cells expressing full-length HA-MST1 or
HA-MST2 wild-type (wt) together with indicated full-length MOB1A versions were subjected to immunoprecipitation (IP) using anti-HA. Complexes were
studied by immunoblotting using anti-myc (top) and anti-HA (middle). Input lysates were analyzed with anti-myc (bottom). The K104E/K105E mutations
caused loss of binding to MST1/2. See Supplementary Fig. 19 for uncropped western blots. b Lysates of Drosophila S2R + cells expressing full-length HA-
Hpo(wt) together with indicated full-length MOB1A versions were subjected to IP using anti-HA. Complexes were studied by immunoblotting using anti-
myc (top) and anti-HA (middle). Input lysates were probed with anti-myc (bottom). Relative molecular weights are shown. See Supplementary Fig. 19 for
uncropped western blots. c Schematic summary of the biochemical and molecular characterization of the indicated MOB1A variants presented in
Supplementary Figs. 5–13. Noteworthy, NDR2 weakly interacted with MOB1(E51K), and Warts and Hpo bound normally to the E51K mutant as judged by
co-immunoprecipitation experiments (marked by an asterisk), hence the E51K mutant was not studied further. d Model of human MOB1A(33–216)
depicting the possibly opposing binding sites on MOB1 of NDR/LATS and MST1/2 kinases. Secondary structure elements of MOB1 are highlighted. The
locations of Glu51, Asp63, and Lys104/Lys105 in MOB1 are indicated
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sufﬁcient to at least in part suppress cancer-related features in
human cancer cells grown in 2D.
Next, we performed anchorage-independent growth assays
(Fig. 4e, f), a more stringent method to determine malignant
transformation in three-dimensional (3D) tissue culture41. In
contrast to our 2D observations (Fig. 4b–d), MOB1(wt) or MOB1
(K104E/K105E), but not MOB1(D63V) or MOB1(D63V/K104E/
K105E), signiﬁcantly suppressed anchorage-independent growth
in 3D (Fig. 4e, f and Supplementary Fig. 14). This suggests that
MOB1 interactions with MST1/2 are dispensable, while MOB1
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Fig. 4 MOB1 binding to LATS1/2 is required to suppress anchorage-independent growth of human cancer cells, while MOB1 binding to MST1/2 is
dispensable. a Immunoblotting with indicated antibodies of cell lysates derived from MCF-7 human breast cancer cells stably expressing the indicated
HA-MOB1 variants or empty vector (EV) as negative control in lane 1. Relative molecular weights are indicated. See Supplementary Fig. 19 for uncropped
western blots. b Proliferation rates of attached MCF-7 cells stably expressing indicated HA-MOB1A variants. The average of three experiments performed
in triplicates with three independent cell pools is shown (n= 3). Statistically signiﬁcant differences between EV and all MOB1 variant expressing cell pools
are indicated (*p< 0.05; **p< 0.01). c Colony formation assays of the MCF-7 cells shown in a. Representative images are displayed. d Quantiﬁcations of
colony formation assays shown in c. The average of three experiments performed in duplicates with three independent cell pools is shown (n= 3;
***p< 0.001; ns, not signiﬁcant). P-values are: wt= 1.03E-05, DV= 5.42E-04, and KEKE= 1.95E-05 for comparison with EV cells. e Soft agar growth
assays of the MCF-7 cells shown in a. Representative images are displayed. f Quantiﬁcations of the soft agar growth assays shown in e. The average of
three experiments performed in duplicates with three independent cell pools is shown (n= 3; *p< 0.05; ns, not signiﬁcant). P-values are: wt= 0.019 and
KEKE= 0.04 for comparison with EV cells. wt, wild-type; DV D63V, KEKE K104E/K105E, DVKEKE D63V/K104E/K105E
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binding to LATS1/2 is important and MOB1 binding to NDR1/2
alone is insufﬁcient in this 3D setting. In general, our anchorage-
independent growth data of human cancer cells (Fig. 4e, f)
mirrored our ﬂy genetics discoveries (see Fig. 5 and 6 and
Supplementary Fig. 16 below), suggesting that tissue culture
experiments performed under more physiological conditions can
reﬂect in vivo tissue overgrowth experiments.
MOB1/Hpo in ﬂy development and tissue growth control. To
study our MOB1 variants in a complex multicellular organism,
we generated and characterized transgenic ﬂies that ubiquitously
expressed our myc-tagged MOB1 versions in a mats mutant
background (Figs. 5 and 6 and Supplementary Fig. 16). As human
MOB1 expression can rescue mats mutants10, 16, this allowed us
to determine the functional signiﬁcance of altering MOB1 bind-
ing in vivo. Using PhiC31-mediated recombination we integrated
our MOB1 variants at the same chromosomal location (89E11 on
chromosome 3) under control of the ubiquitous ubiquitin-63E
promoter (ubi>MOB1, Supplementary Fig. 16a). Western blot-
ting of whole ﬂies conﬁrmed similar expression of myc-tagged
MOB1 variants (Supplementary Fig. 16b).
We then tested which MOB1 transgene can rescue the larval
lethality of mats deﬁcient ﬂies10. As expected, wild-type MOB1
expression rescued the lethality of a null mats trans-heteroallelic
combination (matsroo/matse235, Supplementary Fig. 16c). Like-
wise, mats deﬁcient animals expressing MOB1(K104E/K105E)
were viable and fertile (Supplementary Fig. 16c), suggesting that
stable MOB1/Hpo binding is dispensable for normal ﬂy
development. In contrast, neither MOB1(D63V) nor MOB1
(D63V/K104E/K105E) rescued mats mutants (Supplementary
Fig. 16c), showing that MOB1/Wts complex formation is essential
for normal development, while MOB1 binding to Trc alone is
insufﬁcient to promote normal development.
To test the rescue effect of our MOB1 mutations on the mats
tissue overgrowth phenotype, we generated matsmutant clones in
the head using the eyFLP/FRT system42. Expression of wild-type
MOB1 and MOB1(K104E/K105E) fully rescued the overgrown
and misshapen head phenotype of eyFLP mats animals (compare
Fig. 5b, d with Fig. 5a, f). In contrast, expression of MOB1(D63V)
or MOB1(D63V/K104E/K105E) only partially suppressed the
mats overgrowth phenotype (compare Fig. 5c, e with Fig. 5a, f).
Thus, stable MOB1 binding to Hpo is dispensable for tissue
growth control, while MOB1/Wts complex formation is
necessary.
Finally, we tested the effect of our MOB1 transgenes on Yki
transcriptional activity by examining the levels of Expanded (Ex),
a well-characterized Yki transcriptional target43. We generated
mutant clones for mats in wing imaginal disks (the larval
precursors to the adult wing) using the FLP/FRT system under
control of the heat shock promoter (Fig. 6). While mats clones
displayed a robust increase in Ex expression (Fig. 6a–e)
expression of either wild-type MOB1 or MOB1(K104E/K105E)
restored Ex levels to control levels (Fig. 6f–j, p–t). In contrast, Ex
levels (and therefore Yki activity) were still strongly upregulated
when MOB1(D63V) or MOB1(D63V/K104E/K105E) were
expressed in mats clones (Fig. 6k–o, u–y). Thus, in full agreement
with the animal viability (Supplementary Fig. 16) and head
overgrowth data (Fig. 5), the interaction of MOB1 with Wts is
required to repress Yki activity, while the MOB1/Hpo interaction
is dispensable and MOB1/Trc complex formation alone is
insufﬁcient for a complete rescue.
As previously observed10, mats clones were usually small
(Fig. 6a). Mats mutant clones were rarely recovered in the wing
82B GFP blank
ey-FLP ;; 82B GFP x
82B matsroo, ubi>MOB1(wt)
82B matsroo, ubi>MOB1(KEKE) 82B matsroo, ubi>MOB1(DVKEKE) 82B matsroo
82B matsroo, ubi>MOB1(DV)
d e f
ba c
Fig. 5 Expression of MOB1(wt) or MOB1(K104E/K105E), but not MOB1(D63V) or MOB1(D63V/K104E/K105E), fully suppresses the mats eye overgrowth
phenotype. Shown are frontal views of eyes from female progeny of the indicated genotypes (wt, wild-type; DV D63V, KEKE K104E/K105E, DVKEKE
D63V/K104E/K105E). A wild-type control eye is shown for comparison a. Expression of MOB1(wt) b or MOB1(K104E/K105E) d fully suppress the severe
tissue overgrowth upon eyeless-FLP (ey-FLP) mediated formation of matsmutant clones in the eye (compare b, d with a and f). Expression of MOB1(D63V)
c or MOB1(D63V/K104E/K105E) e does not fully suppress eye overgrowth upon mats loss-of-function (compare c, e with a and f)
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pouch, likely because to their tendency to delaminate due to
excessive overgrowth. Interestingly, although Ex levels were
strongly upregulated in both MOB1(D63V) or MOB1(D63V/
K104E/K105E) expressing clones, MOB1(D63V) expressing
clones were larger and survived readily in the pouch (Fig. 6k),
in contrast to MOB1(D63V/K104E/K105E) expressing clones,
which were more similar to mats clones not expressing MOB1
(compare Fig. 6a, u). In this regard, we also noted that adult heads
expressing MOB1(D63V/K104E/K105E) were more severely
affected than adult heads expressing MOB1(D63V) in mats null
tissue (compare the more rippled appearance of Fig. 5c, e). These
ﬁndings collectively suggest that when MOB1 activity is
weakened by loss of the MOB1/Wts interaction, MOB1 function
is further compromised by loss of the Hpo/MOB1 interaction,
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Fig. 6 Human MOB1(wt) or MOB1(K104/K105E), but not MOB1(D63V) or MOB1(D63V/K104E/K105E), expression suppresses elevated Yki activity in
mats null mutant wing imaginal disk clones. Analysis of Ex expression in wing imaginal disks of the indicated genotypes (wt wild-type, DV D63V, KE K104E/
K105E, DVKE D63V/K104E/K105E). All panels show third instar wing imaginal disks containing mats mutant clones marked by the absence of GFP
expression (green in b, g, l, q, v). GFP-negative mats null clones are indicated by dashed lines. Maximum intensity projections of XY confocal stacks are
shown in red to visualize Expanded (Ex) labeling (red in a, f, k, p, u). X–Z confocal sections through the same wing imaginal disks were acquired c, h,m, r, w.
Nuclei are stained with DAPI in blue. Ex (d, i, n, s, x) and GFP (e, j, o, t, y) protein levels are indicated. All scale bars are 20 µm. As expected, mats null
clones displayed increased Yki activity as judged by elevated Ex levels a–e. Expression of MOB1(wt) f–j or MOB1(K104E/K105E) p–t suppresses Yki activity
to normal levels in matsmutant clones (compare i, s with d), while expression of MOB1(D63V) k–o or MOB1(D63V/K104E/K105E) u–y does not (compare
n, x with d and i)
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while disruption of the Hpo/MOB1 interaction alone does not
affect MOB1 function.
Discussion
Despite extensive progress in elucidating Hippo growth control
signaling, studies comparing the biological signiﬁcance of the
regulatory interactions of MOB1 with Hippo core kinases have
remained elusive. This point is crucial, since loss-of-function of
MOB1 in ﬂies and mice causes the most severe phenotypes of
Hippo core cassette components10, 23, 26, 27, indicating that
MOB1 represents a multipurpose hub in Hippo core signaling. By
combining genetics, structure, molecular, and cell biology our
present study addresses this pressing issue. We uncovered key
mechanisms promoting selective binding of MOB1 to Hippo core
kinases in mammalian and ﬂy cells. Precisely, we discovered that
Asp63 of MOB1 is indispensable for interacting with LATS1/2
and Wts, while Lys104/Lys105 of MOB1 are essential for stable
complex formation with MST1/2 and Hpo. Thus, MOB1 can
differentiate between interactions in the Hippo core cassette,
thereby most likely enabling MOB1 to regulate the speciﬁcity and
amplitude of Hippo core kinase signaling.
While our biochemical and molecular data regarding Asp63 of
MOB1 are further supported by a comparison of crystal struc-
tures of MOB1/NDR2 and MOB1/LATS2 complexes, we can
currently only speculate on the structural level concerning
Lys104/Lys105 of MOB1 and stable complex formation with
MST1/2 (Hpo). Based on available structural data28 one can draw
the conclusion that Pro106 of MOB1 signiﬁcantly contributes to
the MST1 binding surface. Thus, we are tempted to speculate that
modiﬁcations of Lys104/Lys105 of MOB1 impact the neighboring
Pro106 and thereby impair stable MOB1/MST1 complex forma-
tion. Possibly, the positively charged Lys104/Lys105 residues of
MOB1 further bond with the negatively charged phosphorylated
Thr residues on MST1/2 (Hpo). In this regard, the available
crystal structures20, 28 of MOB1/MST1 and MOB1/MST2 com-
plexes cover only a fraction of the possible interactions between
MOB1 and different phospho-threonine residues on MST1/2.
More speciﬁcally, these structures cover MOB1 bound to phos-
phorylated Thr353 and Thr367 of MST1 and phosphorylated
Thr378 of MST2, while MOB1 binding to phosphorylated
Thr329, Thr340, Thr380, and Thr387 of MST1 and phosphory-
lated Thr349, Thr356, and Thr364 of MST2 have been reported20,
28. The MOB1/MST1 and MOB1/MST2 crystal structures20, 28
consistently highlighted Lys153 and R154 of MOB1 as central P0
phosphate coordinating residues of the phospho-threonine on
MST1/2. Thus, we also tested the consequences of Lys153/R154 of
MOB1, hoping to deﬁne an alternative MOB1 mutant that dis-
plays selective loss-of-interaction with human MST1/2 and ﬂy
Hippo. However, the testing of MOB1(K153A/R154A) and
MOB1(K153E/R154E) revealed that Lys153/Arg154 of MOB1 are
important for MST2 as well as LATS2 binding, supporting the
previous notion that Lys153/Arg154 of MOB1 are likely to
represent the core of a more general phospho-serine/threonine
binding domain37. This interpretation is further supported by the
ﬁnding that Lys153/Arg154 of MOB1 are part of the Praja2
binding region38.
Our data indicate that MOB1 binding to the NTRs of NDR1/2
vs. LATS1/2 also differs quantitatively. By determining interac-
tion afﬁnities, we observed an interaction of non-phosphorylated
MOB1 with NDR2, while binding to LATS1 was not detectable.
Phospho-MOB1 bound to LATS1, but interacted with NDR2 at a
much higher afﬁnity. These ﬁndings suggest that MOB1 generally
displays a signiﬁcantly higher afﬁnity for NDR2, hence MOB1-
mediated Hippo signaling may preferentially signal through the
NDR kinase branch, although our biological data indicate that
MOB1/NDR (Trc) complex formation alone is insufﬁcient to
support development and normal tissue growth control. In this
regard, His646 and Val647 of LATS1 (see this study), and pos-
sibly selective inhibitory MOB2 binding to the NTR of NDR1/244,
are promising candidates for the ﬁne-tuning of MOB1-mediated
signaling. Consequently, future studies are warranted to address
these possibilities. In particular, crystal structures of full-length
NDR kinases bound to full-length MOB1 in its non-
phosphorylated vs. phosphorylated state will help to further our
understanding with regard to the recently proposed auto-
inhibition model for MOB1 binding19, 20. Furthermore, the
in vivo importance of MST1/2 (Hpo) mediated phosphorylation
of MOB1 (Mats) needs to be deciphered. In this regard, our
conclusions regarding MOB1 phosphorylation are currently
based on in vitro experiments, which must be cautiously inter-
preted regarding in vivo implications.
By discovering MOB1 variants displaying selective loss-of-
interactions and decrypting the biological signiﬁcance of reg-
ulatory interactions of MOB1 in Hippo core signaling, we believe
that our study helps to settle the recent controversy3, 19, 20, 30, 31
regarding the importance of MOB1 binding to MST1/2 (Hpo). Ni
et al. previously concluded that stable MST2 binding to MOB1
functions as an important step in activating the MST1/2-LATS1/2
kinase cascade20. However, no biological functions were addres-
sed20. In this regard, using a chimeric sensor to measure Wts
conformation in ﬂy tissues, Vrabioiu and Struhl31 found that
MOB1 can act as a Hpo-independent activator of Wts, hence
contrasting the model proposed by Ni et al.20. Manning and
Harvey30 proposed a unifying model, wherein MOB1 acts before
and after Hpo-mediated phosphorylation of Wts and MOB1.
However, in support of Luo and colleagues20, the Sicheri and
Gingras laboratories recently showed that ternary MST1/2-
MOB1-LATS1/2 (NDR1/2) complex formation is important, at
least when tested in vitro28, 29. Conversely, our study rather
supports the model drawn by Vrabioiu and Struhl31, namely that
a ternary complex is not required for MOB1/LATS1 activation
in vivo. Therefore, it is currently difﬁcult to reconcile all pub-
lished data into one general model. Nonetheless, we are proposing
an updated four-step model (Supplementary Fig. 17) attempting
to consolidate these models20, 30, 31 with our discoveries reported
here and other important biochemical data19, 21, 22, 28, 29, 35, 36.
First, activated Hpo (MST1/2) phosphorylates MOB1 to release
MOB1 from an auto-inhibitory conformation19, 20, 22. Sig-
niﬁcantly, this ﬁrst step does not seem to require formation of a
stable Hpo/MOB1 complex (see this study), suggesting that
MST1/2 phosphorylation of MOB1 only requires a brief transient
kinase-substrate interaction. However, we currently do not
understand how MOB1 (Mats) phosphorylation actually ﬁts into
the regulation of Hippo core kinase signaling in vivo. Second,
MOB1 binds to Wts (LATS1/2) to “open up” Wts31. In this
second step the formation of a stable MOB1/Wts complex is
essential (see this study and refs. 21, 22, 35, 36). Third, “open”
LATS1/2 is phosphorylated by MST1/2 in the C-terminal
hydrophobic motif (HM)20, 21. This third step can occur with-
out formation of a stable ternary MST1/2-MOB1-LATS1/2
complex, as proposed by the MST1/2-binding deﬁcient K104E/
K105E mutant characterized in this study. Fourth, HM-
phosphorylated LATS1/2 autophosphorylates on the activation
loop20, 21, a step that can occur independent of MOB1 binding to
LATS1/221. Intriguingly, the MST1/2-MOB1-NDR1/2 signaling
model is very similar, but different17, 45, since MOB1 binding to
NDR1/2 can occur independently of MOB1 phosphorylation (see
this study). Even more importantly, it is crucial to note that our
proposed model (Supplementary Fig. 17) is mainly supported by
in vitro experiments.
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Our study together with the report by Vrabioiu and Struhl31
would argue that the MOB1/Hippo interaction is dispensable for
tissue growth control by Hippo signaling. But we strongly caution
from drawing a broad and general conclusion from these studies,
since we cannot rule out the possibility that the MOB1/Hippo
interaction is only dispensable in selective aspects of tissue growth
control. Thus, our model (Supplementary Fig. 17) may exemplify
a mechanism for a switch-like activation of NDR/LATS kinases in
speciﬁc biological contexts (for example, to ensure abrupt ter-
mination of growth responses), consequently being limited to
speciﬁc biological settings. As a result, much more future research
is warranted to further dissect these subtle, but important, dif-
ferences in the activation mechanisms of LATS1/2 vs. NDR1/2
kinases in speciﬁc physiological contexts.
Surprisingly, our study further revealed that stable MOB1/Hpo
interaction is dispensable for development, tissue growth control
and suppression of Yki activity. We also discovered that the
MOB1/Trc interaction alone is insufﬁcient to normally support
these processes, although it can be sufﬁcient to decrease pro-
liferation of human cancer cells. The MOB1/Wts interaction is
essential for development, tissue growth control, and Yki reg-
ulation in Drosophila, but it can be dispensable for some tumor
suppressive properties of MOB1 in human cells. Therefore, our
study signiﬁcantly advances our understanding of the biological
importance of the regulatory interactions of MOB1 with Hippo
core kinases, in addition to providing structural and molecular
insights into the differential binding of MOB1 to Hippo core
kinases.
In the course of our in vivo studies we noted further interesting
aspects. While disruption of the stable MOB1/Hpo interaction
alone did not have a detectable effect on MOB1 function (see
K104E/K105E mutant), loss of the MOB1/Hpo interaction could
affect MOB1 function in the context of disrupted
MOB1/Wts interaction (see D63V/K104E/K105E mutant). This is
illustrated by the observations that, in the eye overgrowth assay,
D63V/K104E/K105E mutant tissues were noticeably more over-
grown than in K104E/K105E mutants. In the wing clone
experiments, only D63V/K104E/K105E mutants displayed a high
frequency of clone delamination and loss in the wing pouch,
indicative of a strong overgrowth phenotype and similar to the
full mats mutant phenotype. Thus, in the context of a weakened
MOB1 function (i.e. through disrupted MOB1/Wts binding), loss
of the MOB1/Hpo interaction can further reduce the in vivo
function of MOB1.
Another interesting aspect based on our in vivo work is that,
although D63V/K104E/K105E rescued ﬂies showed a strong eye
overgrowth phenotype and Ex upregulation, these phenotypes
were still markedly weaker than the full mats loss-of-function
phenotypes, suggesting that D63V/K104E/K105E can at least
partially rescue the mats mutant phenotype. This could be due to
several reasons. First, as the MOB1/Trc interaction is not dis-
rupted in the D63V/K104E/K105E mutant, this mutant may
partially rescue the mats mutant phenotype through MOB1-
mediated Trc regulation. Indeed, Trc has been proposed to
function partially redundantly with Wts, at least in some con-
texts46. Second, although our data indicate that the D63V/K104E/
K105E mutant is severely impaired in its ability to bind to Wts, it
is nevertheless possible that some low-afﬁnity Wts binding
activity might remain, which possibly is sufﬁcient to partly rescue
the mats mutant phenotype. Third, we cannot exclude the pos-
sibility that other factors, besides the Hippo core kinases, may
facilitate MOB1-mediated Hippo signaling. In this regard, other
binding partners of MOB1 are worth considering, although the
known MOB1 binders Praja238 and Dock847 are not conserved in
ﬂies. Therefore, future experiments are warranted to address this
issue, taking into account recent interactome screens29, 48, 49.
Taken together, our study establishes a major foundation of
MOB1-mediated Hippo core signaling. The Hippo pathway is
essential for tissue growth control and homeostasis1–3, and its
dysregulation has been linked to various human cancers4.
Therefore, our study through providing notable insights into how
MOB1 differentiates between Hippo core kinase deﬁnes a fra-
mework for how these different interactions may function in
different cellular contexts in health and disease. We discovered
that selected regulatory interactions of MOB1 are essential for
development, tissue growth control, and Yki regulation, hence
establishing MOB1 as the central hub of Hippo core signaling,
besides providing structural and molecular insights into the
Hippo core cassette, and establishing key research tools for future
studies of the regulatory interactions of MOB1 in diverse disease-
relevant settings.
Methods
Protein puriﬁcation for structural and biochemical analyses. cDNAs encoding
human MOB1A (residues 33–216), NDR1 (residues 24–87), NDR2 (residues
25–88), LATS1 (residues 618–697 or 640–703), and MST2 (residues 2–392 or
2–308) were subcloned into a modiﬁed pET28a vector (Novagen). NDR1 (24–87,
Y31V), NDR2 (25–88, Y32V), and LATS1 (640–703, V647Y) were generated by
standard PCR mutagenesis. Human LATS2 (residues 603–666) and LATS2
(603–666, V610Y) were codon-optimized, synthesized, and subcloned into a
modiﬁed pET28a vector (Novagen) by Generay Biotechnology. These pET28a-
based constructs were used to express N-terminally 6× His tagged proteins in the E.
coli strain BL21(DE3). BL21(DE3) were from New England BioLabs. Bacteria
carrying pET28a plasmids were grown at 37 °C until they reached an optical
density of 0.6–1.0 at 600 nm. Protein expression was induced by addition of 0.2
mM IPTG (Isopropyl β-D-1-thiogalactopyranoside) and cultures were incubated at
16 °C for additional 12–16 h. After cell lysis with a cell homogenizer (JNBIO) in
lysis buffer (25 mM Tris pH 8.0, 300 mM NaCl, and 20 mM imidazole), followed by
centrifugation, supernatants were subjected to Ni2+-NTA afﬁnity chromatography
(Qiagen) as described by the manufacturer. To form crystals of the MOB1A/NDR2
complex, NDR2 (25–88) and MOB1A (33–216) proteins were incubated at an 1:1
molar ratio at 4 °C in assembly buffer (20 mM Tris pH 8.0, 200 mM NaCl, and 5
mM DTT (Dithiothreitol)), prior to loading onto a HiLoad 16/60 Superdex 200 gel
ﬁltration column (GE Healthcare). Peak fractions were combined and concentrated
to 10–15 mgml−1 for crystallization experiments. Puriﬁed MOB1A (33–216) was
phosphorylated as follows: in a total volume of 10 ml MOB1A (1 mgml−1) was
incubated with MST2 (2–308, 0.002 mgml−1) at 30 °C for 90 min in phosphor-
ylation buffer (40 mM Tris pH 7.5, 10 mM MgCl2, 5 mM DTT, and 0.2 mM ATP).
Completion of the phosphorylation reaction was veriﬁed by the shift of the
MOB1A band in non-denaturing gel electrophoresis conditions.
Crystallization and data collection. Crystals of MOB1A (33–216) bound to
NDR2 (25–88) were grown at 14 °C in crystallization buffer (17% PEG 3350, 0.1 M
HEPES pH 7.5, and 150 mM magnesium chloride) by the hanging-drop vapor-
diffusion method. Crystals were transferred to the crystallization buffer supple-
mented with 25% glycerol before freezing. Using an ADSC Quantum 315r CCD
area detector an X-ray diffraction data-set at was collected at the beamline BL17U1
at Shanghai Synchrotron Radiation Facility (Shanghai, China). Diffraction data
2.10 Å were processed with the HKL2000 software50.
Structure reﬁnement and molecular graphics. The crystal belonged to the space
group P212121, and contained two MOB1A (33–216)‒NDR2 (25–88) complexes in
each asymmetric unit. MOB1 (33–216) molecules in the complex were located by
the molecular replacement method with the CCP4 program Phaser51, 52 using the
published32 structure of MOB1A (33–216) alone (PDB code: 1PI1) as the searching
model. The model of the NDR2 (25–88) fragment was built manually with Coot53.
After reﬁnement by the CCP4 program REFMAC554, the Rwork and Rfree factors
were 15.3 and 24.4%, respectively. The quality of the ﬁnal structure was veriﬁed by
the CCP4 program PROCHECK51, revealing good stereochemistry according to
the Ramachandran plot (99.0, 0.6, and 0.4% for favored, allowed, and disallowed
regions, respectively). The ﬁnal models include residues 33–212 and 33–216 of
MOB1A for chains A and B, respectively, and residues 25–85 and 25–87 of NDR2
for chains C and D, respectively. All ﬁgures displaying protein structures were
generated with PyMOL (http://www.pymol.org). Sequence conservation of MOB1
mapped onto the surface of its crystal structure was generated by the ConSurf
server55.
Isothermal titration calorimetry assays. ITC experiments were performed at
25 °C using an ITC200 system (MicroCal) and the following buffer system: 25 mM
HEPES pH 7.5, 200 mM NaCl, and 1 mM EDTA. Proteins were centrifuged and
degassed before experiments. Typically, ~240 μM MOB1A was injected 20 times in
2 μl aliquots into a 200 μl sample containing ~24 μM of NDR1, NDR2, LATS1, or
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LATS2 proteins in the sample cell. By varying the stoichiometry (n), the enthalpy
for the reaction (ΔH), and the association constant (Ka), data were ﬁtted with the
non-linear least-square method using a single-site binding model with Origin for
ITC version 7.0 (MicroCal).
Gel ﬁltration chromatography. Full-length MOB1A wild-type, D63V or K104E/
K104E cDNAs were subcloned into the pET28a vector, expressed in bacteria and
subsequently puriﬁed as described above for MOB1A (33–216). Puriﬁed full-length
MOB1 proteins were incubated with NDR2 (25–88), LATS1 (618–697), or MST2
(2–392) protein at 4 °C for 20 min in assembly buffer, before the protein mixtures
were loaded onto a HiLoad 16/60 Superdex 200 gel ﬁltration chromatography
column (GE Healthcare) and 1.4 ml fractions were collected. Samples from selected
Superdex 200 fractions were analyzed by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and Coomassie Blue staining. For the complex
formation assay between MOB1A and LATS1, MOB1A protein was in vitro
phosphorylated by MST2 (2-308) as described above prior to incubation with
LATS1 (618-697).
Antibodies for immunoblotting and immunoprecipitations. For immunoblot-
ting, samples were resolved by 8 or 12% SDS-PAGE, followed by transfer onto
Immobilon-P membranes (Millipore). Membranes were blocked for at least one
hour with TBST (50 mM Tris pH 7.5, 150 mM NaCl, 0.5% Tween 20) containing
5% skim milk powder and then probed overnight with primary antibody. Bound
antibodies were detected by horseradish peroxidase-linked secondary antibodies,
followed by enhanced chemiluminescence. For co-immunoprecipitations, cells
were collected by centrifugation at 1000 × g for 3 min, followed by lysis in corre-
sponding buffers (see below). After 30 min, cell lysates were centrifuged for 10 min
at 16,000 × g at 4 °C before preclearing with protein A-Sepharose, followed by
immunoprecipitation with 12CA5 antibody pre-bound to protein A-Sepharose.
Beads were washed at least three times with the corresponding lysis buffer before
samples were analyzed by SDS-PAGE and immunoblotting. The characterization of
LATS1/2, NDR1/2, MST1/2, Warts, Trc, and Hpo binding to MOB1A variants was
carried out in low-stringency buffer (30 mM HEPES pH 7.4, 20 mM beta-glycer-
ophosphate, 20 mM KCl, 1% TX-100, 1 mM EGTA, 2 mM NaF, 1 mM Na3VO4,
1 mM benzamidine, 4 μM leupeptin, 0.5 mM PMSF, 1 μM microcystin, and 1 mM
DTT). Alternatively (Supplementary Fig. 8), co-immunoprecipitation experiments
were performed in RIPA (9806, Cell Signaling; 20 mM Tris pH 7.5, 150 mM NaCl,
1 mM EDTA, 1 mM EGTA, 1% NP-40, 1% (w/v) sodium deoxycholate, 2.5 mM
sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na3VO4, 1 μg ml−1 leu-
peptin, 1 mM benzamidine, 0.5 mM PMSF, 1 μM microcystin, and 1 mM DTT),
PBS-E (phosphate-buffered saline (10 mM Na2HPO4, 2 mM KH2PO4, 137 mM
NaCl, 2.7 mM KCl at pH 7.4) supplemented with 1 mM EDTA, 1% (v/v) Triton X-
100, 50 mM NaF, 1 mM Na3VO4, 1 mM benzamidine, 4 μM leupeptin, 0.5 mM
PMSF, 1 μMmicrocystin, and 1 mM DTT) or standard lysis buffer (20 mM Tris pH
8.0, 150 mM NaCl, 10% glycerol, 1% NP-40, 5 mM EDTA, 0.5 mM EGTA, 20 mM
β-glycerophosphate, 50 mM NaF, 1 mM Na3VO4, 1 mM benzamidine, 4 μM leu-
peptin, 0.5 mM PMSF, 1 μM microcystin, and 1 mM DTT). Anti-GAPDH
(GTX100118 from GeneTex; used at 1:1,000 on ﬂy extracts) conﬁrmed equal
loading. Anti-HA 12CA5 (used at 1:500), anti-myc 9E10 (used at 1:50), anti-α-
tubulin YL1/2 (used at 1:100), and anti-MOB1 (used at 1:250) antibodies have been
described39, 45, 56, 57. Additional anti-HA antibodies were from Cell Signaling
(C29F4; used at 1:1000) and Roche (3F10; used at 1:1000). Anti-myc (71D10; used
at 1:1000), anti-MST1 (3682; used at 1:2500), anti-MST2 (3952; used at 1:2500),
anti-T12-P (8843; used at 1:1000), and anti-T35-P (8699; used at 1:1000) were from
Cell Signaling. Anti-actin (sc-1616; used at 1:1000) were from Santa Cruz Bio-
technology. Anti-GAPDH (Mab374; used at 1:1000), anti-Mal (Maltose binding
protein; E8032; used at 1:5000), and anti-GST (ab6613; used at 1:5000) were from
Millipore, New England BioLabs, and Abcam, respectively. Secondary antibodies
were purchased from GE Healthcare (NA931, NA934, and NA935; used at 1:5000
and 1:10,000, respectively) and Santa Cruz Biotechnology (sc-2020; used at 1:5000).
Primary and secondary antibodies for immunoﬂuorescence studies (all used at
1:500) were rabbit anti-Expanded (kindly provided by A. Laughon, University of
Wisconsin–Madison, USA), mouse anti-β-gal (Promega, Z3781), Rhodamine Red
X-conjugated anti-rabbit and FITC-conjugated anti-mouse antibodies (both from
Jackson ImmunoResearch).
Kinase assays. Human full-length MOB1A cDNA variants were inserted into the
pMal-c2 vector (New England BioLabs) using BamHI and XhoI/SalI sites to gen-
erate pMal-MOB1A plasmids, which can express MOB1A N-terminally tagged by
the maltose binding protein. Recombinant Mal-MOB1A proteins were expressed in
E. coli BL21(DE3) at 30 °C and puriﬁed using amylose resin (E8021, New England
BioLabs). Brieﬂy, single-bacteria colonies containing pMal-MOB1A were grown
overnight at 37 °C, followed by 1:10 dilution before IPTG was added at 100 µM and
bacteria were incubated for another 3 h at 30 °C. Subsequently, cultures were
centrifuged at 1400×g for 10 min, followed by addition of Mal lysis buffer (20 mM
Tris pH 7.5, 1 mM EDTA, 200 mM NaCl) and sonication at 70% amplitude
(model:VCx 130, Sonics Vibra Cell). Lysates were centrifuged and the supernatant
was clariﬁed by ﬁltration (40 µm cell strainer) before addition of amylose-resin and
overnight incubation at 4 °C. The following day, the protein-amylose resin mix was
washed excessively with Mal lysis buffer, followed by elution of Mal-MOB1A
proteins in 20 mM Tris pH 7.5 buffer containing 10 mM maltose. Recombinant
Mal-MOB1A proteins were dialyzed in 20 mM Tris pH 7.5 containing 10% (v/v)
glycerol, followed by quantiﬁcation using SDS-PAGE and Coomassie staining.
Recombinant full-length wild-type GST-MST1 (M9697) and GST-MST2 (S6573)
were from Sigma. To produce immunopuriﬁed full-length wild-type HA-tagged
Hpo kinase, Drosophila S2R + cells were transfected with pAW_HA-Hpo and
processed for immunoprecipitation (IP) using anti-HA antibody and standard IP
conditions as deﬁned above. Immunopuriﬁed Hpo proteins were washed twice
with MST1/2 (Hpo) kinase buffer (5 mM Tris pH 7.5, 2.5 mM beta-glyceropho-
sphate, 1 mM EGTA, 1 mM Na3VO4, 4 mM MgCl2, 0.1 mM DTT), before kinase
reactions were performed as follows: per reaction 200 ng of Mal-MOB1A proteins
were incubated at 30 °C for 30 min in 20 μl of kinase reaction buffer (5 mM Tris pH
7.5, 100 μM ATP, 2.5 mM beta-glycerophosphate, 1 mM EGTA, 1 mM Na3VO4, 4
mM MgCl2, 0.1 mM DTT) in the absence or presence of GST-MST1/2 (50 ng per
reaction) or immunopuriﬁed Hpo. The reactions were stopped by the addition of
Laemmli buffer, before proteins were separated by SDS-PAGE, followed by
immunoblotting as outlined above.
Construction of plasmids. Human MOB1A/B, NDR1/2, LATS1/2, and MST1/2
cDNAs cloned in pcDNA3-based vectors were described previously21, 35, 39, 44, 45, 56.
pcDNA3_myc-hMOB1A(wt) served as template for the generation of the following
MOB1A mutants by PCR-based mutagenesis: E49R, E51K, E55K, D63V, K104E,
K105E, K135E, H161Q, H164Q, K104E/K105E, D127K/D128K, K153A/R154A,
K153E/R154E, E51K/K104E/K105E, and D63V/K104E/K105E. To subclone N-
terminally HA-tagged MOB1 cDNAs into the pLEX vector, the tagged cDNAs were
ﬁrst inserted using KpnI and XhoI into the pENTR-3C plasmid (Invitrogen) and
then recombined into the pLEX destination plasmid using Gateway technology
(Invitrogen). To subclone HA-tagged MOB1 cDNAs into the pCMV-R-neo plas-
mid58, the tagged cDNAs were inserted using PmeI and XhoI. Hpo and Warts
cDNAs have been described59. The pAW vector, Mats (LD47533) and Trc
(LD37189) cDNAs were from the Drosophila Genomics Resource Center (Indiana
University, USA). To subclone N-terminally tagged cDNAs into the pAW or
pKC26w-pUbiq ﬂy expression vectors, the tagged cDNAs were ﬁrst inserted into
the pENTR-3C plasmid (Invitrogen) and then recombined into these two desti-
nation plasmids using Gateway technology (Invitrogen). Myc-hMOB1A variants,
myc-Mats, HA-Trc, and HA-Hpo were inserted into pENTR-3C using KpnI and
XhoI. HA-Warts was inserted into pENTR-3C using KpnI and NotI. All constructs
were conﬁrmed by sequence analysis of the entire cDNAs at every cloning step.
Cell culture and transient transfections. HEK293, HEK293T, MCF-7, and
HCT116 cells were originally obtained from ATCC and grown at 37 °C in 5% CO2
humiﬁed chambers in DMEM (D6429, Sigma) supplemented with 10% fetal bovine
serum (FBS; F7524, Sigma) and penicillin/streptomycin. Cells were authenticated
through STR (Short Tandem Repeat) proﬁling and mycoplasma tested by Micro-
synth (Switzerland). Exponentially growing HEK293 cells were plated at a con-
sistent conﬂuence and transfected with plasmids using Fugene 6 (E2692, Promega)
according to the manufacturer’s instructions as described45, 60. 1.2 × 10 E6 of
HCT116 cells were transiently transfected with 1.0 μg pcDNA3-based plasmids
using the nucleofector kit V (VCA-1003, Lonza) as deﬁned by the manufacturer.
Drosophila S2R + cells were maintained at 24 °C in Schneider’s Drosophila Medium
(217200024, Invitrogen) supplemented with heat inactivated FBS (10082147,
Invitrogen) and penicillin/streptomycin. S2R + cells were transiently transfected
with pAW-based plasmids using Effectene (301425, Qiagen) according to the
manufacturer’s instructions.
Generation of stable cell line pools. To generate stable lentiviral cell pools using
pLEX_HA-MOB1 plasmids, 8 × 10 E6 of the HEK293T packaging cells were
transfected with 2.4 μg of pMD.G, 0.8 μg of p8.91, and 4.8 μg of pLEX plasmids
using Lipofectamine 2000 (11668, Invitrogen) as recommended by the manu-
facturer. Tissue culture supernatants were harvested 24 h later, passed through a
0.45-μm ﬁlter and added to the target cell lines in the presence of 1 μg ml−1
polybrene. Infected cells were selected by growth in the presence of 2.5 μg ml−1
puromycin. Stable pools (uncloned mass culture) of cells were maintained in
DMEM supplemented with 10% FBS and 0.6 μg ml−1 puromycin. Retroviral pools
(uncloned mass culture) were generated using pCMV-R-retro based plasmids and
maintained in the presence of G418 as described elsewhere58, 61.
Proliferation and colony formation assays. HCT116 transiently transfected with
pcDNA3-based plasmids were seeded 24 h post-transfection, or stable MCF-7 cell
line pools were analyzed. Media were replenished every 72 h during the duration of
experiments. For cell proliferation analysis, cells were seeded at deﬁned densities
(5 × 10 E4 cells per well) in triplicates in 12-well plates, followed by non-invasive
IncuCyte live cell imaging (Essen BioScience) to measure the kinetics of cell
growth/proliferation based on area (conﬂuence) metrics. Phase-contrast images
were continuously collected on IncuCyte ZOOM (Essen BioScience) for at least one
week. A speciﬁc processing deﬁnition (Phase-contrast processing module) was
applied to count objects (cells) for the duration of the assay. The Phase object area
was expressed as relative cell conﬂuency for each well at each time point and
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subsequently exported into GraphPad Prism Software for ﬁnal analysis. To evaluate
colony formation, 1,000 cells were seeded per well (6-well format). After 8–12 days,
colonies were ﬁxed with methanol/acidic acid (3:1) for 5 min at room temperature,
stained with 0.5% (w/v) crystal violet for 15 min at room temperature, washed with
water and ﬁnally scanned using the G:BOX HR gel documentation system (Syn-
gene). Colonies composed of at least 50 cells were score as positive.
Soft agar assays for anchorage-independent growth. After trypsinization, cells
were passed 4-5 times through a 21 G syringe, before 1 × 10 E4 cells were resus-
pended in complete medium (DMEM containing 10% FBS and appropriate anti-
biotics) with 0.6% agarose (16520050, Thermo Fisher Scientiﬁc), and subsequently
cultured in wells (6-well format) underlaid by a layer of 1% agarose in complete
medium and overlaid with complete medium without agarose. Top layer media
were replenished every 72 h. After three weeks, colonies were stained with 2.5 mg
ml−1 thiazolyl blue tetrazolium blue (MTT, Sigma), scanned, and quantiﬁed. Cell
clusters of at least 50 cells were scored as colonies.
Drosophila melanogaster genetics. All ﬂies were maintained at 25 °C unless
otherwise stated. The matsroo and matse235 ﬂy strains, carrying mats null alleles,
have been reported10. The mats gene is located on chromosome 3 at 94A12
(FlyBase ID: FBgn0038965). The PhiC31 integrase-mediated site-speciﬁc recom-
bination method was used to express human MOB1 variants from one identical
chromosomal location (PBac{y[ + ]-attP-9A}VK00027 integrated at 89E11 on
chromosome 3) (see also Supplementary Fig. 16a). Brieﬂy, N-terminally myc-
tagged MOB1 cDNA variants were cloned into the pKC26w-pUbiq vector that
allows expression of the cloned fragments under the ubiquitin-63E promoter62.
pKC26w-pUbiq_myc-MOB1 plasmids were injected into y[1] w[1118]; PBac{y[
+ ]-attP-9A}VK00027 ﬂies (FlyBase ID: FBst0009744) and stable transformants
were identiﬁed by the presence of the mini-white+ marker. Injections of embryos
with pKC26w_pUbiq _myc-hMOB1A plasmids and the initial generation of stable
transformants were performed by BestGene Inc. (Chino Hills, USA). The ubi>
MOB1 transgenes were recombined with the matsroo allele on an FRT82B-carrying
chromosome by meiotic recombination followed by selection in medium con-
taining 100 µl of 25 mgml−1 neomycin. Upon appearance of eggs, vials were heat-
shocked at 37 °C for 1 h 1–2 times every day until pupae appeared. After balancing,
the matsroo allele and FRT82B sites were conﬁrmed by PCR genotyping (see below).
To generate adult eyes mosaic for homozygous mutant and heterozygous wild-type
tissue, these recombinant lines were crossed to eyFLP;; FRT82B GFP/TM6B (eyFLP
expresses FLP only in the eye and head capsule42). To generate mutant clones in
wing imaginal disks, we crossed our lines to hsFLP; FRT82B GFP. Larvae were heat-
shocked at 37 °C for 1 h 3 days after egg laying, followed by dissection at wandering
L3 stage (6 or 7 days after egg laying).
Genotypes of transgenic ﬂies used in this study. Figure 5:
a. yw eyFLP/+ ;; FRT82B GFP/FRT82B blank
b. yw eyFLP/+ ;; FRT82B GFP/FRT82B matsroo, ubi>MOB1-wt
c. yw eyFLP/+ ;; FRT82B GFP/FRT82B matsroo, ubi>MOB1-DV
d. yw eyFLP/+ ;; FRT82B GFP/FRT82B matsroo, ubi>MOB1-KEKE
e. yw eyFLP/+ ;; FRT82B GFP/FRT82B matsroo, ubi>MOB1-DVKEKE
f. yw eyFLP/+ ;; FRT82B GFP/FRT82B matsroo
Figure 6:
a-e. yw hsFLP/+ ;; FRT82B GFP/FRT82B matsroo
f-j. yw hsFLP/+ ;; FRT82B GFP/FRT82B matsroo, ubi >MOB1-wt
k-o. yw hsFLP/+ ;; FRT82B GFP/FRT82B matsroo, ubi>MOB1-DV
p-t. yw hsFLP/+ ;; FRT82B GFP/FRT82B matsroo, ubi>MOB1-KEKE
u-y. yw hsFLP/+ ;; FRT82B GFP/FRT82B matsroo, ubi>MOB1-DVKEKE
Immunoﬂuorescencse microscopy of Drosophila imaginal disks. All procedures
were carried out at room temperature, protected from light, unless otherwise stated.
Wandering L3 larvae were dissected in ice-cold phosphate-buffered saline (PBS).
Brieﬂy, larvae were torn in half, the anterior half inverted, and undesired tissues
were removed (central nervous system, fat body, and salivary glands), leaving only
the imaginal disks attached to the inverted carcass. Carcasses were then ﬁxed in 4%
paraformaldehyde in PBS at room temperature for 30 min, washed several times in
PBS containing 0.1% Triton-X100 (PBST), followed by permeabilization for 25 min
in PBS containing 0.3% Triton-X100 and 1 h pre-blocking with 10% normal goat
serum (NGS) in PBST. Subsequently, samples were incubated with primary anti-
body at 4 °C overnight. Then samples were washed with PBST, pre-blocked once
more with 10% NGS in PBST, followed by incubation with secondary antibody for
at least 2 h. Finally, samples were washed with PBST, stained for 20 min with 1 µg
ml−1 DAPI in PBST, before washing once more with PBST and mounting of the
disks in Vectashield mounting medium (Vector Labs). Samples were stored at 4 °C
until imaging. Confocal images were acquired on a Zeiss LSM510 laser scanning
microscope using a water immersion ×40 objective. To visualize apical surfaces
(where Expanded protein is localized), Z-stacks of between 8 and 20 × 1 µm
sections were collected, and then processed as maximum intensity projections.
Images were processed using ImageJ, and ﬁgures prepared using Adobe software.
Western blotting and PCR genotyping of transgenic ﬂies. To analyze adult ﬂies
using immunoblotting, three ﬂies per genotype were frozen at −80 °C overnight,
followed by homogenization on ice in 20 µl of Laemmli sample buffer per ﬂy
(1610737, Bio-Rad,) using a Squisher manual homogenizer (Zymo Research). After
boiling samples at 95 °C for 10 min, samples were centrifuged and supernatants
transferred to fresh tubes. Finally, DTT was added to a ﬁnal concentration of
50 mM and equal volumes of samples were analyzed by SDS-PAGE, followed by
western blotting. For PCR genotyping, ﬂies were collected, frozen in liquid nitro-
gen, and subsequently crushed using a micropestle, followed by preparation of
genomic DNA using a Qiagen kit (69506). Genomic DNA was stored at – 20 °C,
followed by PCR genotyping using the following primers: 5′-GCCGCTCAAGA-
TAGCCAGAT-3′ and 5′-GCACACTTCCTGGAACCGCTCGCATC-3′ to detect
the Roo transposon; and 5′-AGAGGCGCTTCGTCTACGGAGCGACA-3′ and
5′-CGGCAAGCAGGCATCGCCATGGGTC-3′ to detect the FRT site.
Statistical analysis. Graphics and statistical analyses were carried out using the
GraphPad Prism software. Data are presented as mean± s.e.m., unless stated
otherwise. The signiﬁcance of differences between the means or the population
distributions was determined using two-tailed unpaired Student t-test. Differences
were considered statistically signiﬁcant when p-values were below 0.05 (*), 0.01
(**), or 0.001 (***). p-values are listed in the corresponding ﬁgure legends where
appropriate.
Data availability. The coordinates and structure factor ﬁles of the complex of
human MOB1 (residues 33–216) bound to NDR2 (residues 25–88) have been
deposited in the Protein Data Bank (PDB) with accession number 5XQZ. All
relevant data are available from the corresponding authors upon reasonable
request.
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